Oak Longevity vs Ro.co: Compounded Low Cost vs FDA-Approved Wegovy Pill
Oak Longevity vs Ro.co quickly comes down to priorities: Oak Longevity is built for cost conscious patients seeking compounded GLP-1s with semaglutide starting at $133/month and tirzepatide at $199/month, while Ro.co gives access to the FDA-approved Wegovy pill and lets you get started online for $39. Early verdict: choose Oak Longevity if lowest out of pocket for compounded injectables matters most, choose Ro.co if you want an FDA-approved oral option.
Explore Oak Longevity pricing and plans
How these platforms differ in three key areas
The comparison below focuses on the most distinctive supported differences between Oak Longevity and Ro.co: medication type and regulatory status, starting cost and pricing model, and the care and delivery process. Each point contrasts both providers directly using only the supplied evidence.
Medication type and regulatory status
Oak Longevity primarily offers compounded semaglutide and compounded tirzepatide. The source explicitly notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Ro.co offers access to the Wegovy pill, described as the first and only FDA-approved oral GLP-1 weight loss medication. That means Ro.co supplies an FDA-approved finished product while Oak supplies compounded versions of the same active ingredients.
Starting price and pricing model
Oak Longevity advertises semaglutide from $133/month and tirzepatide from $199/month with one flat price covering all dosages. Oak emphasizes no subscriptions, no membership fees, and billing monthly on a non recurring basis so you are not auto charged. Ro.co promotes a low entry point with get started online for just $39; ongoing pricing depends on the treatment plan and branded medication costs which the source says can be significantly higher than compounded alternatives. The evidence does not supply exact ongoing prices for Ro.co beyond the $39 start.
Compare Oak Longevity pricing details
Care process and delivery differences
Oak Longevity runs an asynchronous clinical review with no video call required; patients complete an online questionnaire and a licensed clinician reviews the case. Oak includes free health coaching and free shipping with tracking and notes same day approval is available for qualifying patients. Ro.co also provides online clinical review where treatment is available only when a licensed clinician determines it is medically appropriate. Ro.co emphasizes full service telehealth platform features and regulatory clarity tied to offering FDA-approved finished products.
Side by side table: Oak Longevity vs Ro.co
| Criteria | Oak Longevity | Ro.co |
|---|---|---|
| Medication offering | Compounded semaglutide and tirzepatide | Wegovy pill, FDA-approved oral GLP-1 |
| Regulatory status | Compounded medications not FDA-approved | FDA-approved finished product for Wegovy pill |
| Starting price | Semaglutide from $133/mo, tirzepatide from $199/mo | Get started online for $39 |
| Pricing model | One flat price for all dosages, billed monthly non recurring | Low entry fee; ongoing branded medication pricing varies |
| Care process | Asynchronous clinician review, no video call required | Licensed clinician review; full service telehealth platform |
| Extras | Free health coaching and free shipping with tracking | Emphasis on regulatory clarity and injection free option |
Practical implications for patients
Cost focused patients with uncomplicated health histories who want the most affordable compounded GLP-1 online may prefer Oak Longevity because of the clearly stated low starting prices, one price across dosages, no subscription, free coaching and free shipping. Patients who are injection averse or who prefer an FDA-evaluated finished product should consider Ro.co because it is the only mainstream platform on the list offering the Wegovy pill, the FDA-approved oral option. Ro.co starts at $39 to get started online but ongoing branded medication costs may be higher than compounded options.
Start with Ro.co and the Wegovy pill
Safety and regulatory notes to consider
Oak Longevity explicitly states compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Ro.co offers an FDA-approved oral GLP-1 which carries regulatory evaluation as a finished product. Both platforms require a licensed clinician to determine treatment is medically appropriate. The supplied evidence does not provide comparative clinical outcomes or insurance coverage details.
Choose one if
Choose Oak Longevity if you are cost conscious, comfortable with compounded GLP-1s, want semaglutide from $133/month or tirzepatide from $199/month, prefer no subscription billing, and value free health coaching and free shipping with an asynchronous clinical review.
Choose Ro.co if you want access to the FDA-approved Wegovy pill, require an oral injection free option, and value regulatory clarity even if ongoing branded medication costs may be higher than compounded alternatives.